These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 567922)
1. [On "contact activation inhibitors" released from bovine plasma high molecular weight kininogen by plasma kallikrein (author's transl)]. Iwanaga S; Kato H; Ham YN; Oh-Ishi S; Katori M Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):575-8. PubMed ID: 567922 [No Abstract] [Full Text] [Related]
2. Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen. Matheson RT; Miller DR; Lacombe MJ; Han YN; Iwanaga S; Kato H; wuepper KD J Clin Invest; 1976 Dec; 58(6):1395-406. PubMed ID: 993350 [TBL] [Abstract][Full Text] [Related]
3. Primary structure of bovine plasma high-molecular-weight kininogen. Characterization of carbohydrate-free fragment 1.2 (fragment X) released by the action of plasma kallikrein and its biological activity. Han YN; Kato H; Iwanaga S; Oh-Ishi S; Katori M J Biochem; 1978 Jan; 83(1):213-21. PubMed ID: 564343 [No Abstract] [Full Text] [Related]
4. [Purification and enzyme study of kininogens I and II from human plasma]. Díaz A; Henriques OB Acta Physiol Lat Am; 1976; 26(4):248-53. PubMed ID: 1032268 [TBL] [Abstract][Full Text] [Related]
5. Increased activity of plasma and tissue kallikreins, plasma kininase II and salivary kallikrein in pemphigus foliaceus (fogo selvagem). Rosatelli TB; Roselino AM; Dellalibera-Joviliano R; Reis ML; Donadi EA Br J Dermatol; 2005 Apr; 152(4):650-7. PubMed ID: 15840094 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin. Kleniewski J; Blankenship DT; Cardin AD; Donaldson V J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355 [TBL] [Abstract][Full Text] [Related]
7. Cleavage of human high molecular weight kininogen by human plasma kallikrein. Nagasawa S; Nakayasu T Adv Exp Med Biol; 1979; 120B():163-71. PubMed ID: 517233 [No Abstract] [Full Text] [Related]
8. Bovine plasma high molecular weight kininogen: the amino acid sequence of fragment 1 (glycopeptide) released by the action of plasma kallikrein and its location in the precursor protein. Han YN; Kato H; Iwanaga S; Suzuki T FEBS Lett; 1976 Mar; 63(1):197-200. PubMed ID: 1261681 [No Abstract] [Full Text] [Related]
9. The carbohydrate structure of a glycopeptide released by the action of plasma kallikrein on bovine plasma high-molecular-weight kininogen. Endo Y; Yamashita K; Han YN; Iwanaga S; Kobata A J Biochem; 1977 Aug; 82(2):545-50. PubMed ID: 914796 [TBL] [Abstract][Full Text] [Related]
10. Study of the effect of high molecular weight kininogen upon the fluid-phase inactivation of kallikrein by C1 inhibitor. Silverberg M; Longo J; Kaplan AP J Biol Chem; 1986 Nov; 261(32):14965-8. PubMed ID: 3639874 [TBL] [Abstract][Full Text] [Related]
11. Limited proteolysis of HMW kininogen by plasma kallikrein in man--evidence for a processing mechanism different from the bovine system. Müller-Esterl W; Hock H; Rauth G; Kellermann J; Lottspeich F; Henschen A Adv Exp Med Biol; 1986; 198 Pt A():97-103. PubMed ID: 3643720 [TBL] [Abstract][Full Text] [Related]
12. [Effect of the stimulators and inhibitors of the central dopaminergic structures on the kininogen level and kallikrein activity in the rat plasma]. Kleinrok Z; Szurska G Ann Univ Mariae Curie Sklodowska Med; 1980; 35():57-61. PubMed ID: 6924835 [No Abstract] [Full Text] [Related]
13. High molecular weight kininogen: its inability to correct the clotting of kininogen-deficient plasma after cleavage of bradykinin by plasma kallikrein, plasmin or trypsin. Chan JY; Movat HZ; Burrowes CE Thromb Res; 1979; 14(6):817-24. PubMed ID: 157559 [No Abstract] [Full Text] [Related]
14. Studies on the primary structure of bovine high-molecular-weight kininogen. Amino acid sequence of a fragment ("histidine-rich peptide") released by plasma kallikrein. Han YN; Komiya M; Iwanaga S; Suzuki T J Biochem; 1975 Jan; 77(1?):55-68. PubMed ID: 1169237 [TBL] [Abstract][Full Text] [Related]
15. Primary structure of bovine high molecular weight kininogen: chemical compositions of kinin-free kininogen and peptide fragments released by plasma kallikrein. Han YN; Komiya M; Kato H; Iwanaga S; Suzuki T FEBS Lett; 1975 Oct; 57(3):254-8. PubMed ID: 1181197 [No Abstract] [Full Text] [Related]
16. Actions of urinary kallikrein, plasmin, and other kininogenases on bovine plasma high-molecular-weight kininogen. Han YN; Kato H; Iwanaga S; Komiya M J Biochem; 1978 Jan; 83(1):223-35. PubMed ID: 146707 [No Abstract] [Full Text] [Related]
17. [Purification of kininogen II (LMW) from human plasma]. Díaz A; Henriques OB Acta Physiol Lat Am; 1976; 26(4):243-7. PubMed ID: 1032267 [TBL] [Abstract][Full Text] [Related]
18. The accelerating effect of bovine plasma HMW kininogen on the surface-mediated activation of factor XII: generation of a derivative form (active kininogen) with maximal cofactor activity by limited proteolysis. Sugo T; Kato H; Iwanaga S; Fujii S Thromb Res; 1981 Nov; 24(4):329-37. PubMed ID: 6917562 [No Abstract] [Full Text] [Related]
19. Kallikrein-kinin system in diabetic patients. Uehara S; Isogawa S; Sakamoto W; Hirayama A Arzneimittelforschung; 1988 May; 38(5):721-3. PubMed ID: 3415716 [TBL] [Abstract][Full Text] [Related]
20. [Kallikrein activation and kininogen level in rat venous and arterial blood in acute myocardial ischemia]. Gomazkov OA; Komissarova NV; Bol'shakova LV; Shimkovich MV Biull Eksp Biol Med; 1973 Aug; 76(8):25-7. PubMed ID: 4544262 [No Abstract] [Full Text] [Related] [Next] [New Search]